Fintel reports that on January 7, 2025, Jefferies upgraded their outlook for Instil Bio (NasdaqCM:TIL) from Hold to Buy.

Fintel reports that on January 7, 2025, Jefferies upgraded their outlook for Royal Gold (NasdaqGS:RGLD) from Hold to Buy.

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Anand Rathi believes multiple players can co-exist in the quick commerce space. It initiated coverage on Zomato and Swiggy ...

Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...

Jefferies analyst Sheila Kahyaoglu lowered the firm’s price target on Leidos (LDOS) to $160 from $175 and keeps a Hold rating on the shares.

Jefferies analyst Brent Thill upgraded Procore (PCOR) to Buy from Hold with a price target of $100, up from $80. The firm expects a favorable ...

Shares of Zomato fell by 4.8% following Jefferies' downgrade of the stock from 'buy' to 'hold' and a 18% cut in the target ...